Cleared Traditional

K160673 - Insulin Algorithms System (FDA 510(k) Clearance)

Class II General Hospital device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K160673 · Insulin Algorithms · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2017
Decision
454d
Days
Class 2
Risk

K160673 is an FDA 510(k) clearance for the Insulin Algorithms System. Classified as Calculator, Drug Dose (product code NDC), Class II - Special Controls.

Submitted by Insulin Algorithms (Los Angeles, US). The FDA issued a Cleared decision on June 7, 2017 after a review of 454 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 868.1890 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General Hospital submissions.

View all Insulin Algorithms devices

Submission Details

510(k) Number K160673 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 10, 2016
Decision Date June 07, 2017
Days to Decision 454 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
326d slower than avg
Panel avg: 128d · This submission: 454d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code NDC Calculator, Drug Dose
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - NDC Calculator, Drug Dose

All 53
Devices cleared under the same product code (NDC) and FDA review panel - the closest regulatory comparables to K160673.
EndoTool IV Cloud 1.0
K260910 · Glooko, Inc. · May 2026
MiniMed Go App
K253512 · Medtronic Minimed · Jan 2026
UpDoc
K253281 · Updoc, Inc. · Dec 2025
T1D1
K252104 · Comerge AG · Aug 2025
EndoTool IV (3.1)
K241088 · Monarch Medical Technologies · Dec 2024
InPen System App (MMT-8060 (iOS), MMT-8061 (Android))
K242775 · Medtronic Minimed · Nov 2024